Date published: 2026-4-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Bordetella pertussis toxin (CAS 70323-44-3)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
Islet-activating protein; PTX
Application:
Bordetella pertussis toxin is a biologically active toxin for antibody capture, ELISA, LINE assay, and cytotoxicity studies
CAS Number:
70323-44-3
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Bordetella pertussis toxin is a multifunctional virulence factor that is extensively studied for its role in disrupting host immune responses. The research on this toxin delves into its ability to catalyze the ADP-ribosylation of G protein-coupled receptors, which alters signaling pathways within host cells. This disruption is key to understanding the modulation of immune cell function and the pathogenesis of whooping cough. Bordetella pertussis toxin also serves as a valuable probe in the study of intracellular signaling, particularly the regulation of adenylate cyclase and the resulting changes in cyclic AMP concentrations. Investigations involving the toxin provide insights into its contribution to the evasion of host defenses and the mechanisms by which it promotes bacterial survival and colonization. Additionally, Bordetella pertussis toxin is for examining the interactions between bacterial pathogens and the respiratory tract, offering a better understanding of respiratory infections and their complications.


Bordetella pertussis toxin (CAS 70323-44-3) References

  1. Interaction of human Tamm-Horsfall glycoprotein with Bordetella pertussis toxin.  |  Menozzi, FD., et al. 2002. Microbiology (Reading). 148: 1193-1201. PMID: 11932463
  2. Description of a hybridoma bank towards Bordetella pertussis toxin and surface antigens.  |  Poolman, JT., et al. 1990. Microb Pathog. 8: 377-82. PMID: 1980000
  3. Simultaneous determination of Bordetella pertussis toxin and filamentous haemagglutinin concentrations by hydroxyapatite high-performance liquid chromatography.  |  Chong, P., et al. 1990. J Chromatogr. 512: 227-36. PMID: 2172264
  4. Bordetella Pertussis Toxin does not induce the release of pro-inflammatory cytokines in human whole blood.  |  Bache, C., et al. 2012. Med Microbiol Immunol. 201: 327-35. PMID: 22527330
  5. G proteins Gαi1/3 are critical targets for Bordetella pertussis toxin-induced vasoactive amine sensitization.  |  Diehl, SA., et al. 2014. Infect Immun. 82: 773-82. PMID: 24478091
  6. Effects of Bordetella pertussis toxin on catecholamine inhibition of insulin release from intact and electrically permeabilized rat islets.  |  Persaud, SJ., et al. 1989. Biochem J. 258: 669-75. PMID: 2543359
  7. Construction and characterization of Bordetella pertussis toxin mutants.  |  Black, WJ. and Falkow, S. 1987. Infect Immun. 55: 2465-70. PMID: 2888733
  8. Pharmacological Cyclophilin Inhibitors Prevent Intoxication of Mammalian Cells with Bordetella pertussis Toxin.  |  Ernst, K., et al. 2018. Toxins (Basel). 10: PMID: 29723951
  9. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG35-55 in the Mouse.  |  Giralt, M., et al. 2018. Methods Mol Biol. 1791: 227-232. PMID: 30006713
  10. The Potential Role of Subclinical Bordetella pertussis Infection in Epilepsy.  |  Rubin, K. and Glazer, S. 2019. Front Cell Infect Microbiol. 9: 302. PMID: 31555605
  11. Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model.  |  Bowers, CE., et al. 2022. J Vis Exp.. PMID: 35098942
  12. Demyelination Lesions Do Not Correlate with Clinical Manifestations by Bordetella pertussis Toxin Concentrations.  |  Perussolo, MC., et al. 2022. Life (Basel). 12: PMID: 35888052
  13. Rapid purification of Bordetella pertussis toxin by alternating affinity and hydrophobic chromatography.  |  Svoboda, M., et al. 1986. Anal Biochem. 159: 402-11. PMID: 3826625
  14. Inhibition of bovine rod outer segment GTPase by Bordetella pertussis toxin.  |  Watkins, PA., et al. 1984. J Biol Chem. 259: 1378-81. PMID: 6141165
  15. Effects of Bordetella pertussis toxin pretreatment on the antiarrhythmic action of ischaemic preconditioning in anaesthetized rats.  |  Piacentini, L., et al. 1995. Br J Pharmacol. 114: 755-60. PMID: 7773535

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Bordetella pertussis toxin, 50 µg

sc-471083
50 µg
$441.00